Effect of first-line molecular targeted agents on the efficacy of second-line bevacizumab-containing regimen for metastatic colorectal cancer.

被引：0
|
作者：
Hasegawa, Hiroko
Taniguchi, Hiroya
Mitani, Seiichiro
Komori, Azusa
Masuishi, Toshiki
Narita, Yukiya
Kadowaki, Shigenori
Ura, Takashi
Andoh, Masashi
Muro, Kei
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi 464, Japan
[2] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
748
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Selection of Second-line Anti-angiogenic Agents After Failure of Bevacizumab-containing First-line Chemotherapy in Metastatic Colorectal Cancer
    Boku, Narikazu
    Yamamoto, Shun
    [J]. CLINICAL COLORECTAL CANCER, 2018, 17 (04) : 251 - 254
  • [2] Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody
    Hasegawa, Hiroko
    Taniguchi, Hiroya
    Mitani, Seiichiro
    Masuishi, Toshiki
    Komori, Azusa
    Narita, Yukiya
    Kadowaki, Shigenori
    Ura, Takashi
    Ando, Masashi
    Yatabe, Yasushi
    Muro, Kei
    [J]. ONCOLOGY, 2017, 92 (04) : 205 - 212
  • [3] Real-world Direct Health Care Costs for Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab-containing Regimens in First-line or First-line Through Second-line Therapy
    Johnston, Stephen
    Wilson, Kathleen
    Varker, Helen
    Malangone-Monaco, Elisabetta
    Juneau, Paul
    Riehle, Ellen
    Satram-Hoang, Sacha
    Sommer, Nicolas
    Ogale, Sarika
    [J]. CLINICAL COLORECTAL CANCER, 2017, 16 (04) : 386 - +
  • [4] Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer
    Bazarbashi, S.
    Hakoun, A. M.
    Gad, A. M.
    Elshenawy, M. A.
    Aljubran, A.
    Alzahrani, A. M.
    Eldali, A.
    [J]. CURRENT ONCOLOGY, 2019, 26 (01) : E24 - E29
  • [5] Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment
    Bai, Long
    Zhang, Dong-sheng
    Wu, Wen-jing
    Ren, Chao
    Wang, De-shen
    Wang, Feng
    Qiu, Miao-zhen
    Xu, Rui-hua
    [J]. MEDICAL ONCOLOGY, 2015, 32 (02)
  • [6] Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment
    Long Bai
    Dong-sheng Zhang
    Wen-jing Wu
    Chao Ren
    De-shen Wang
    Feng Wang
    Miao-zhen Qiu
    Rui-hua Xu
    [J]. Medical Oncology, 2015, 32
  • [7] Comparative analysis of the effectiveness of second-line bevacizumab plus chemotherapy in second-line therapy in metastatic colorectal cancer.
    Smagulova, Kaldigul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
    Shun Yamamoto
    Kengo Nagashima
    Takeshi Kawakami
    Seiichiro Mitani
    Masato Komoda
    Yasushi Tsuji
    Naoki Izawa
    Kentaro Kawakami
    Yoshiyuki Yamamoto
    Akitaka Makiyama
    Kentaro Yamazaki
    Toshiki Masuishi
    Taito Esaki
    Takako Eguchi Nakajima
    Hiroyuki Okuda
    Toshikazu Moriwaki
    Narikazu Boku
    [J]. BMC Cancer, 21
  • [9] Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer
    Yamamoto, Shun
    Nagashima, Kengo
    Kawakami, Takeshi
    Mitani, Seiichiro
    Komoda, Masato
    Tsuji, Yasushi
    Izawa, Naoki
    Kawakami, Kentaro
    Yamamoto, Yoshiyuki
    Makiyama, Akitaka
    Yamazaki, Kentaro
    Masuishi, Toshiki
    Esaki, Taito
    Nakajima, Takako Eguchi
    Okuda, Hiroyuki
    Moriwaki, Toshikazu
    Boku, Narikazu
    [J]. BMC CANCER, 2021, 21 (01)
  • [10] A prospective, multicenter, observational study of bevacizumab in combined with chemotherapy as first-line or second-line treatment in Chinese metastatic colorectal cancer
    Qin, Shukui
    Deng, Yanhong
    Bi, Feng
    Liu, Tian Shu
    Liu, Yunpeng
    Zhang, Suzhan
    Xu, Jianming
    Shu Yongqian
    Xu, Nong
    Wu, Changping
    Wang, Xin
    Zhong, Haijun
    Feng, Jifeng
    He, Yulong
    Yang, Jianwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345